Almirall, S.A.

€11.22As of Sun 8 Nov 2026, 12:00 UTC
BME:ALMHealthcare
Country Spain
PE (Fwd) •••
TSR 10Y CAGR (0.18%)
Div yield 1.67%
ROE 3.95%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.08
PE TTM 40.61
TSR TTM (8.75%)
Mkt cap €2.443B
ROIC 4.32%
SE Grade™
Value
Quality
Moat
Consensus
Reference
€12
6.26%
(30.20%)
Buy 4|3|5|9|4
4Q25
1Q26
2Q26
3Q26
Earnings per share€
0.10
0.11
0.11
0.12
1.22%
4.92%
13.49%
21.18%
Revenue€M
286.0
290.6
289.2
298.7
11.19%
7.18%
3.53%
3.01%
Peers (US$2.744B)
Cap (US$)
PE
1.708B
19.00x
Capital
TTM
5Y
10Y
Leveragex
1.762
0.155
0.153
EBIT/Intx
0.510
0.180
0.165
Own earn%
123.25
(31.28)
(27.14)
Sh yield%
46.42
21.84
21.13
Owners
Insiders/Inst%
2.00
44.86
Short interest%
4.54
SBC / revenue%
4.74
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
8
Op margin range%
20–24
$1 testx
—
Incr. ROIC%
3